These results further suggest that SNFYT may exert therapeutic effects through the IL-17 signaling pathway, TNF signaling pathway, and HIF-1 signaling pathway regulating the inflammatory cascade response after ischemic stroke. This evidence concerns the gene IL17A and ischemic stroke.